Company intelligence / Profile preview

MEDIRA

Balingen, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

MEDIRA is a private German medical technology company developing cardiovascular implants for structural heart disease. The company focuses on minimally invasive and catheter-based solutions intended to make treatment of complex heart and aortic conditions easier, safer, and faster for physicians. Its disclosed lead program, BREVA, is an endovascular stent graft and catheter-based aortic valve prosthesis combination for acute Type A aortic dissection using an "Endo-Bentall" concept. MEDIRA also appears to have intellectual property related to prosthetic valve devices for mitral valve insufficiency. The company is based in Balingen, Germany and is led by founder and CEO Thomas J. Bogenschütz.

Therapeutic areas: Cardiovascular
Modalities: DeviceBiologic
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on MEDIRA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEDIRA.

Explore the full profile